The Next-Generation of Neisseria gonorrhoeae Antimicrobial Resistance Testing

Robert F Potter; Eric M Ransom; Carey-Ann D Burnham

doi:10.1093/clinchem/hvab026

The Next-Generation of Neisseria gonorrhoeae Antimicrobial Resistance Testing

Clin Chem. 2021 Mar 31;67(4):573-575. doi: 10.1093/clinchem/hvab026.

Authors

Robert F Potter¹, Eric M Ransom¹, Carey-Ann D Burnham^{1

2

3}

Affiliations

¹ Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO.
² Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO.
³ Departments of Pediatrics and Medicine, Washington University School of Medicine, St. Louis, MO.

PMID: 33720324
DOI: 10.1093/clinchem/hvab026

No abstract available

Keywords: GC; WGS; clinical microbiology; culture-independent; drug prediction; nanopore; resistance genes; resistance prediction; sequencing; susceptibility testing.

Publication types

Editorial
Comment

MeSH terms

Anti-Bacterial Agents* / pharmacology
Anti-Bacterial Agents* / therapeutic use
Drug Resistance, Bacterial
Humans
Microbial Sensitivity Tests
Neisseria gonorrhoeae* / drug effects
Neisseria gonorrhoeae* / genetics
Whole Genome Sequencing

Substances

Anti-Bacterial Agents